Target intelligence / Profile preview

Ribosomal protein L34 pseudogene 14 (RPL34P14)

Target
RPL34P14
Molecular classification
Other (processed pseudogene)
01

Overview

**RPL34P14** (Ribosomal protein L34 pseudogene 14) is a *processed pseudogene* corresponding to the ribosomal protein L34 gene. It does not encode a functional protein and is not expressed to produce a ribosomal subunit. Pseudogenes like RPL34P14 are generally non-functional genomic sequences derived from related protein-coding genes, in this case from RPL34. There is no evidence in current databases that this pseudogene is associated with molecular functions, disease mechanisms, or responses to therapeutic drugs. It is not considered a therapeutic target and does not have known biological activity[3][6]. **Key notes:** - *RPL34P14* is distinct from *RPL34*, which is a protein-coding gene with documented roles in ribosome function and several cancers[1][5][9][13]. - Several processed pseudogenes for ribosomal protein genes exist throughout the genome and are catalogued by nomenclature committees as pseudogenes, not as functional targets[6][3]. - If you are interested in the *functional ribosomal protein L34*, refer to *RPL34* instead, as *RPL34P14* is a non-functional sequence. **Conclusion:** RPL34P14 is a pseudogene, not a functional gene or therapeutic target, with no protein product, biological function, or clinical relevance. Its inclusion as a drug target or disease biomarker is incorrect.

Other names
Ribosomal protein L34 pseudogene 14RPL34P14

Beyond the preview

Go deeper on Ribosomal protein L34 pseudogene 14 (RPL34P14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L34 pseudogene 14 (RPL34P14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call